These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10107734)

  • 1. Biotech industry considers foreign competition measure.
    Margolis RE
    Healthspan; 1990 Nov; 7(10):19-20. PubMed ID: 10107734
    [No Abstract]   [Full Text] [Related]  

  • 2. The CREATE Act: increasing costs associated with the biotech industry?
    Mills AE; Chen DT; Gillon JJ; Tereskerz PM
    Nat Biotechnol; 2006 Jul; 24(7):785-6. PubMed ID: 16841059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic patents: gatekeeper to the promised cures.
    Westin LP
    Thomas Jefferson Law Rev; 2002; 25(1):271-99. PubMed ID: 15164741
    [No Abstract]   [Full Text] [Related]  

  • 5. Color as a trademark under the Lanham Act: confusion in the circuits and the need for uniformity.
    Carraway JC
    Law Contemp Probl; 1994; 57(4):243-79. PubMed ID: 10140661
    [No Abstract]   [Full Text] [Related]  

  • 6. How many lawyers does it take...greed and legal wrangling could stifle the medical revolution.
    New Sci; 2002 May; 174(2343):3. PubMed ID: 12731531
    [No Abstract]   [Full Text] [Related]  

  • 7. US Supreme Court decision could compromise biotech patents.
    Robertson D
    Nat Biotechnol; 2001 May; 19(5):394. PubMed ID: 11328981
    [No Abstract]   [Full Text] [Related]  

  • 8. The 1992 biotechnology agenda: a message for candidates Bush and Clinton.
    Duzan SA
    Healthspan; 1992 Sep; 9(8):12-5. PubMed ID: 10122052
    [No Abstract]   [Full Text] [Related]  

  • 9. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotech in post-TRIPS India.
    Ramani SV; Pradhan P; Ravi M
    Nat Biotechnol; 2005 Jan; 23(1):18-9. PubMed ID: 15637608
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotechnology patents: strategies for meeting economic and ethical concerns.
    Gold ER
    Nat Genet; 2002 Apr; 30(4):359. PubMed ID: 11925560
    [No Abstract]   [Full Text] [Related]  

  • 12. Research interactions between industry and academia: a corporate perspective.
    Citron P
    Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
    [No Abstract]   [Full Text] [Related]  

  • 13. Proposed changes to patent code loom over biotech industry.
    Coombs A
    Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010
    [No Abstract]   [Full Text] [Related]  

  • 14. The gene patenting controversy: a convergence of law, economic interests, and ethics.
    Kevles DJ; Berkowitz A
    Brooklyn Law Rev; 2001; 67(1):233-48. PubMed ID: 12645549
    [No Abstract]   [Full Text] [Related]  

  • 15. Napster case spills into biotech sector.
    Bouchie A
    Nat Biotechnol; 2004 Sep; 22(9):1185-6. PubMed ID: 15384189
    [No Abstract]   [Full Text] [Related]  

  • 16. Patent fight sparks biological warfare in the drug industry.
    Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662
    [No Abstract]   [Full Text] [Related]  

  • 17. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.
    Teitelbaum R; Cohen M
    Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990
    [No Abstract]   [Full Text] [Related]  

  • 18. Patent threat in emerging economies shifts to biotech.
    Jayaranam K
    Nat Biotechnol; 2008 May; 26(5):481-3. PubMed ID: 18464760
    [No Abstract]   [Full Text] [Related]  

  • 19. Executive compensation at private biotech companies: a competitive environment.
    Rychlik B; Dipierro M
    Nat Biotechnol; 2008 Jan; 26(1):133-4. PubMed ID: 18183026
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotech bailout? A rescue of some sort will be needed to save a large subset of the US biotechnology industry.
    Nat Immunol; 2009 Jul; 10(7):667. PubMed ID: 19536186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.